Healthcare Industry News: Alphatec Holdings
News Release - November 16, 2011
Alphatec Spine Appoints New Senior Vice President, Global Marketing and Asia PacificCurt Jennewine, Seasoned Medical Device Marketing and Sales Executive, Agrees to Join Alphatec Spine
CARLSBAD, Calif., Nov. 16, 2011 -- (Healthcare Sales & Marketing Network) -- Alphatec Holdings, Inc. (Nasdaq:ATEC ), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that Curt Jennewine, a seasoned medical device marketing and sales executive, has agreed to join the Company as its Senior Vice President, Global Marketing and Asia Pacific.
Since 2008 Mr. Jennewine had been the Vice President, Marketing at Zimmer's Trauma division. Prior to working at Zimmer, Mr. Jennewine held roles of increasing responsibility in both marketing and sales at each of Abbott Diabetes Care and Guidant Corporation's Japanese vascular intervention unit.
"We are extremely excited to have Curt Jennewine join Alphatec Spine," said Dirk Kuyper, the Company's President and CEO. "Throughout his career Curt has consistently been recognized for his strategic vision and for achieving outstanding results with respect to both marketing and sales, both in the U.S. and internationally, and we look forward to Curt joining the senior management team at Alphatec Spine."
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC ). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company's mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient's quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis, stenosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its U.S. operations, the Company also markets its products in over 50 international markets through its affiliate, Scient'x S.A.S., via a direct salesforce in France, Italy and the United Kingdom and via independent distributors in the rest of Europe, the Middle East and Africa, South America and Latin America. In Asia and Australia, the Company markets its products through its subsidiary, Alphatec Pacific, Inc., and through Scient'x's distributors in China, Korea and Australia.
Source: Alphatec spine
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.